10 tracked public figures made calls on LLY. Every pick graded against the S&P 500 over matching windows.
| Who | Signal | Date | Return | S&P Same Window | Source |
|---|---|---|---|---|---|
| SELL | Feb 24, 2026 | ✓ Correct | — | source ↗ | |
|
AB
|
BUY | Feb 27, 2026 | -17.5% | +4.2% | source ↗ |
|
DK
|
BUY | Feb 07, 2026 | -16.9% | +3.1% | source ↗ |
|
DK
|
BUY | Feb 24, 2026 | -16.7% | +4.0% | source ↗ |
|
JC
|
BUY | Feb 25, 2026 | -15.6% | +3.2% | source ↗ |
| BUY | Feb 25, 2026 | -15.1% | +2.7% | source ↗ | |
|
MC
|
BUY | Mar 16, 2026 | -12.2% | +6.9% | source ↗ |
| BUY | Apr 25, 2024 | +19.8% | +42.0% | source ↗ | |
|
RW
|
SELL | Mar 12, 2026 | ✓ Correct | — | source ↗ |
| SELL | May 12, 2025 | ✓ Correct | — | source ↗ | |
| BUY | Dec 25, 2024 | +9.3% | +18.9% | source ↗ |
GotReceipts tracks public buy and sell signals for Eli Lilly (LLY) and measures outcomes over matched windows. For this ticker model, performance vs the S&P 500 is based on BUY/ADD calls only.
SELL/REDUCE calls are graded directionally and shown as Correct, Incorrect, or Pending. That way, you can quickly see whether following public buy calls added value versus simply holding the index.